Neil Edward Carter

Title: Neil Edward Carter: Innovator in Pharmaceutical Chemistry

Introduction

Neil Edward Carter is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes related to morphine derivatives. With a total of three patents to his name, Carter's work has implications for pain management and drug formulation.

Latest Patents

Carter's latest patents include a process for making morphine-6-glucuronide or substituted morphine-6-glucuronide. This innovative method involves the conjugation of a glucuronate ester with morphine in the presence of a Lewis acid catalyst, while avoiding the use of silver catalysts and barium hydroxide. Another significant patent is an enzymatic process for making morphine-6-glucuronide, which focuses on the selective enzymatic cleavage of the 3-glucuronide moiety in morphine-3, 6-glucuronide using at least one beta-glucuronide.

Career Highlights

Carter is currently associated with Salford Ultrafine Chemicals & Research Ltd., where he continues to advance his research in pharmaceutical applications. His work has been instrumental in enhancing the understanding and production of morphine derivatives, which are crucial for effective pain relief.

Collaborations

Carter has collaborated with notable colleagues, including Feodor Scheinmann and Richard Talbot Brown. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Neil Edward Carter's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to impact the development of effective pain management solutions.